Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ari Raphael
29 years of experience
accreditations :
Clinic is certified :
Immunotherapy in Tel Aviv typically costs from $9,800 to $15,500. Total expenses depend on the specific drug protocol, cancer stage, and whether treatment involves advanced cell engineering. Patients save around 88% compared to the US, where this procedure costs $30,000 on average. Standard packages in Tel Aviv often include hospital stays and professional transfers to the clinic.
Bookimed Expert Insight: Tel Aviv serves as Israel's primary hub for clinical oncology research and high-volume immunotherapy centers. Clinics here offer unique access to the Israeli National Genomic Medicine Initiative for precise treatment selection. Sourasky Medical Center (Ichilov) achieves a 90% success rate by integrating computational biology into patient protocols. Expert Ari Raphael specifically leads trials using liquid biopsies to predict patient responses before treatment begins.
| Israel | Turkey | Austria | |
| Immunotherapy | from $2,400 | from $2,200 | from $30,000 |
| Immunotherapy for prostate cancer | from $2,250 | from $12,000 | from $30,000 |
| Immunotherapy with Keytruda (Pembolizumab) | from $9,800 | from $3,300 | from $15,000 |
| Sarcoma Immunotherapy | - | from $18,000 | from $60,000 |
| Immunotherapy for lung cancer | - | from $18,000 | from $30,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
Leading immunotherapy trials at Sourasky Medical Center – Dr. Raphael specializes in genomic profiling and intra-tumoral injections for thoracic cancers.
Dr. Pelles Sharon specializes in immunotherapy, including treatments like Keytruda, at Sourasky Medical Center (Ichilov).
Prof. Merimsky leads immunotherapy research at Sourasky Medical Center, with decades of expertise in advanced cancer treatments.
Dr. Sarid, a senior oncologist at Ichilov, specializes in biological cancer therapy with over 30 published articles on cancer treatments.
Written by Kateryna Zamkovska